Exome Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-227,821	Closed	-$1.49M	–	73
2024 Q1	$1.49M	Buy	+227,821	New	+$1.49M	1.28%	36